AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Tandem Diabetes Care to Announce Third Quarter 2019 Financial Results on November 4, 2019

October 14, 2019

SAN DIEGO--(BUSINESS WIRE)--Oct 14, 2019--

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2019 results after the financial markets close on Monday, November 4, 2019. The Company will hold a conference call and simultaneous webcast on the same day at 4:30pm Eastern Time (1:30pm Pacific Time), to discuss its third quarter 2019 financial and operating results.

Conference Call/Webcast Details:
Date:
November 4, 2019
Time: 4:30pm Eastern Time (1:30pm Pacific Time)
Toll Free Dial-In Number: (855) 427-4396
International Dial-In Number: (484) 756-4261
Conference ID: 5578474
Webcast Link:https://edge.media-server.com/mmc/p/m3mspf36

An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. ( www.tandemdiabetes.com ) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191014005644/en/

CONTACT: Media Contact:

Steve Sabicer

714-907-6264

ssabicer@thesabicergroup.com Investor Contact:

Susan Morrison

858-366-6900 x7005

smorrison@tandemdiabetes.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: DIABETES MEDICAL DEVICES OTHER HEALTH HEALTH MEDICAL SUPPLIES

SOURCE: Tandem Diabetes Care, Inc.

Copyright Business Wire 2019.

PUB: 10/14/2019 04:05 PM/DISC: 10/14/2019 04:05 PM

http://www.businesswire.com/news/home/20191014005644/en